0001683168-23-000343.txt : 20230125
0001683168-23-000343.hdr.sgml : 20230125
20230125171755
ACCESSION NUMBER: 0001683168-23-000343
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230123
FILED AS OF DATE: 20230125
DATE AS OF CHANGE: 20230125
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: OBrien Geoffrey
CENTRAL INDEX KEY: 0001589471
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-33185
FILM NUMBER: 23553141
MAIL ADDRESS:
STREET 1: 4275 EXECUTIVE SQUARE
STREET 2: SUITE 650
CITY: LA JOLLA
STATE: CA
ZIP: 92037
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: MEDICINOVA INC
CENTRAL INDEX KEY: 0001226616
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 330927979
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 4275 EXECUTIVE SQUARE
STREET 2: SUITE 300
CITY: LA JOLLA
STATE: CA
ZIP: 92037
BUSINESS PHONE: 858-373-1500
MAIL ADDRESS:
STREET 1: 4275 EXECUTIVE SQUARE
STREET 2: SUITE 300
CITY: LA JOLLA
STATE: CA
ZIP: 92037
4
1
ownership.xml
X0306
4
2023-01-23
0
0001226616
MEDICINOVA INC
MNOV
0001589471
OBrien Geoffrey
C/O MEDICINOVA, INC.
4275 EXECUTIVE SQUARE, SUITE 300
LA JOLLA
CA
92037
0
1
0
0
Vice President
Employee Stock Option (Right to Buy)
2.25
2023-01-23
4
A
0
76950
0
A
2023-01-23
2032-01-26
Common Stock
76950
76950
D
On January 27, 2022 the reporting person was granted an option to purchase 81,000 shares of common stock. The option vests based on the satisfaction of certain performance criteria for the fiscal year ended December 31, 2022. Such performance criteria for 2022 were achieved at the 95% attainment level, resulting in vesting of the option as to 76,950 shares.
/s/ Yuichi Iwaki, attorney-in-fact
2023-01-25